MD&M BIOMEDigital 2021: Wearables – Where Are They Headed?
As wearable medical devices become increasingly common for more and more complex applications, developers are facing questions are about the industry’s direction and how they will protect consumers.
You may also be interested in...
A trial of Insulet’s Omnipod 5 trial in children and adults showed improvements in time and range and hemoglobin A1c after three months of use compared to standard therapy.
The topic is central to the Patient Engagement Advisory Committee, which recently got its tenure extended. It also fits into the FDA’s thinking on real-world evidence and total product lifecycle approach.
The new system supports both Medidata and third-party wearable sensors to manage health technology data in clinical trials.